Drug intelligence / Profile preview

PsoriaFilm

Development stage: Preclinical
Lead developer: Velius
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Small Molecules
Administration: Topical, Transdermal

Overview

**PsoriaFilm** is a Velius investigational nanotechnology-enabled topical/transdermal film product for psoriasis and eczema. It combines calcipotriol, a vitamin D analog that activates the vitamin D receptor, with an unspecified corticosteroid intended to activate the glucocorticoid receptor locally. The film platform is designed to amplify percutaneous delivery into affected skin, aiming to reduce inflammation and modulate keratinocyte and immune-cell differentiation and proliferation without injectable corticosteroid administration.

Other names: PsoriaFilmPsoriafilm Rx

Targets

VDR (Vitamin D receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on PsoriaFilm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PsoriaFilm.

Explore the full profile